CNSP

SEC source: 0001683168-26-006552 · ownership.xml · derivative · entry 2

Levin Rami · CIK 0002102719 · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,250

Underlying: Common Stock · 4,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Company common stock.

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: On January 1, 2026, the reporting person was granted 19,000 restricted stock units, vesting as follows: 25% on the six-month anniversary of the grant date, 25% on the twelve-month anniversary of the grant date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.

F2 · derivative.expiration_date: On January 1, 2026, the reporting person was granted 19,000 restricted stock units, vesting as follows: 25% on the six-month anniversary of the grant date, 25% on the twelve-month anniversary of the grant date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.

F2 · balance_after: On January 1, 2026, the reporting person was granted 19,000 restricted stock units, vesting as follows: 25% on the six-month anniversary of the grant date, 25% on the twelve-month anniversary of the grant date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.

SEC source: 0001683168-26-006552 · ownership.xml · nonDerivative · entry 1

Levin Rami · CIK 0002102719 · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001683168-26-004145 · ownership.xml · nonDerivative · entry 1

Charles Faith L. · CIK 0001853985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,100

SEC source: 0001683168-26-006553 · ownership.xml · nonDerivative · entry 1

Fisher Michal · CIK 0002139619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

SEC source: 0001683168-26-001489 · ownership.xml · derivative · entry 1

O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,500

Underlying: Common Stock · 9,500 shares

Expires 2036-03-02

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Company common stock.

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The restricted stock units set forth in the table vest as follows: 25% on the six-month anniversary of the transaction date, 25% on the twelve-month anniversary of the transaction date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.

SEC source: 0001683168-26-001491 · ownership.xml · derivative · entry 1

Faulkner Eric · CIK 0002113815 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,500

Underlying: Common Stock · 9,500 shares

Expires 2036-03-02

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Company common stock.

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The restricted stock units set forth in the table vest as follows: 25% on the six-month anniversary of the transaction date, 25% on the twelve-month anniversary of the transaction date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.

SEC source: 0001683168-26-000016 · ownership.xml · derivative · entry 1

Levin Rami · CIK 0002102719 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2036-01-01

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Company common stock.

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The restricted stock units set forth in the table vest as follows: 25% on the six-month anniversary of the transaction date, 25% on the twelve-month anniversary of the transaction date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.

SEC source: 0001683168-25-008565 · ownership.xml · derivative · entry 1

Mahery Amy · CIK 0002008489 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,517

Underlying: Common Stock · 1,517 shares

Expires 2035-11-17

F1 · date: The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on June 6, 2025, subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025 (the "Shareholder Approval Date").

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The options set forth in the table vest in four equal quarterly installments commencing on the Shareholder Approval Date, subject to the reporting person's continued employment on each vesting date.

SEC source: 0001683168-25-008563 · ownership.xml · derivative · entry 1

Charles Faith L. · CIK 0001853985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,517

Underlying: Common Stock · 1,517 shares

Expires 2035-11-17

F1 · date: The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on June 6, 2025, subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025 (the "Shareholder Approval Date").

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The options set forth in the table vest in four equal quarterly installments commencing on the Shareholder Approval Date, subject to the reporting person's continued employment on each vesting date.

SEC source: 0001683168-25-008562 · ownership.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,881

Underlying: Common Stock · 4,881 shares

Expires 2035-11-17

F1 · date: The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on March 11, 2025 (the "Grant Date"), subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025.

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The options set forth in the table vest as follows: 50% on the six-month anniversary of the Grant Date, 25% on the 12-month anniversary of the Grant Date, and 25% on the 18-month anniversary of the Grant Date, subject to the reporting person's continued employment on each vesting date.

SEC source: 0001683168-25-008564 · ownership.xml · derivative · entry 1

Climaco John M · CIK 0001546797 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,761

Underlying: Common Stock · 9,761 shares

Expires 2035-11-17

F1 · date: The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on March 11, 2025 (the "Grant Date"), subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025.

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The options set forth in the table vest as follows: 50% on the six-month anniversary of the Grant Date, 25% on the 12-month anniversary of the Grant Date, and 25% on the 18-month anniversary of the Grant Date, subject to the reporting person's continued employment on each vesting date.

SEC source: 0001683168-25-008576 · ownership.xml · derivative · entry 1

Keyes Jeffry R. · CIK 0001557736 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,517

Underlying: Common Stock · 1,517 shares

Expires 2035-11-17

F1 · date: The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on June 6, 2025, subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025 (the "Shareholder Approval Date").

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The options set forth in the table vest in four equal quarterly installments commencing on the Shareholder Approval Date, subject to the reporting person's continued employment on each vesting date.

SEC source: 0001683168-25-008566 · ownership.xml · derivative · entry 1

Cockroft Bettina M. · CIK 0001900452 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,517

Underlying: Common Stock · 1,517 shares

Expires 2035-11-17

F1 · date: The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on June 6, 2025, subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025 (the "Shareholder Approval Date").

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The options set forth in the table vest in four equal quarterly installments commencing on the Shareholder Approval Date, subject to the reporting person's continued employment on each vesting date.

SEC source: 0001683168-25-008561 · ownership.xml · derivative · entry 1

Gumulka Jerzy · CIK 0001793252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,517

Underlying: Common Stock · 1,517 shares

Expires 2035-11-17

F1 · date: The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on June 6, 2025, subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025 (the "Shareholder Approval Date").

F3 · price: Issued in connection with the reporting person's employment with the Company.

F2 · derivative.exercise_date: The options set forth in the table vest in four equal quarterly installments commencing on the Shareholder Approval Date, subject to the reporting person's continued employment on each vesting date.

SEC source: 0001683168-24-002290 · ownership.xml · derivative · entry 2

Mahery Amy · CIK 0002008489 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,420

Underlying: Common Stock · 17,500 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company common stock.

F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

F1 · derivative.expiration_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-24-002290 · ownership.xml · derivative · entry 1

Mahery Amy · CIK 0002008489 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,920

Underlying: Common Stock · 17,500 shares

Expires 2034-04-08

F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-24-002283 · ownership.xml · derivative · entry 2

Charles Faith L. · CIK 0001853985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,815

Underlying: Common Stock · 17,500 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company common stock.

F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

F1 · derivative.expiration_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-24-002283 · ownership.xml · derivative · entry 1

Charles Faith L. · CIK 0001853985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,315

Underlying: Common Stock · 17,500 shares

Expires 2034-04-08

F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-24-002286 · ownership.xml · derivative · entry 2

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 241.572

Underlying: Common Stock · 40,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Company common stock.

F2 · price: Issued in connection with the reporting person's employment with the Company.

F4 · derivative.exercise_date: The restricted stock units set forth in the table vest in eight equal quarterly installments over two years.

F4 · derivative.expiration_date: The restricted stock units set forth in the table vest in eight equal quarterly installments over two years.

SEC source: 0001683168-24-002286 · ownership.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201.572

Underlying: Common Stock · 40,000 shares

Expires 2034-04-08

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The options set forth in the table vest in 36 equal monthly installments over three years.

SEC source: 0001683168-24-002284 · ownership.xml · derivative · entry 2

Climaco John M · CIK 0001546797 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 559,533

Underlying: Common Stock · 83,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Company common stock.

F2 · price: Issued in connection with the reporting person's employment with the Company.

F4 · derivative.exercise_date: The restricted stock units set forth in the table vest in eight equal quarterly installments over two years.

F4 · derivative.expiration_date: The restricted stock units set forth in the table vest in eight equal quarterly installments over two years.

SEC source: 0001683168-24-002284 · ownership.xml · derivative · entry 1

Climaco John M · CIK 0001546797 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 476,533

Underlying: Common Stock · 83,000 shares

Expires 2034-04-08

F2 · price: Issued in connection with the reporting person's employment with the Company.

F1 · derivative.exercise_date: The options set forth in the table vest in 36 equal monthly installments over three years.

SEC source: 0001683168-24-002289 · ownership.xml · derivative · entry 2

Keyes Jeffry R. · CIK 0001557736 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,428

Underlying: Common Stock · 17,500 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company common stock.

F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

F1 · derivative.expiration_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-24-002289 · ownership.xml · derivative · entry 1

Keyes Jeffry R. · CIK 0001557736 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,928

Underlying: Common Stock · 17,500 shares

Expires 2034-04-08

F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-24-002288 · ownership.xml · derivative · entry 2

Gumulka Jerzy · CIK 0001793252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,594

Underlying: Common Stock · 17,500 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company common stock.

F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

F1 · derivative.expiration_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-24-002288 · ownership.xml · derivative · entry 1

Gumulka Jerzy · CIK 0001793252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,594

Underlying: Common Stock · 17,500 shares

Expires 2034-04-08

F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-24-002285 · ownership.xml · derivative · entry 2

Cockroft Bettina M. · CIK 0001900452 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,074

Underlying: Common Stock · 17,500 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company common stock.

F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

F1 · derivative.expiration_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-24-002285 · ownership.xml · derivative · entry 1

Cockroft Bettina M. · CIK 0001900452 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,574

Underlying: Common Stock · 17,500 shares

Expires 2034-04-08

F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-24-002287 · ownership.xml · derivative · entry 2

Evans Carl Anthony · CIK 0001792582 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,094

Underlying: Common Stock · 17,500 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company common stock.

F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

F1 · derivative.expiration_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-24-002287 · ownership.xml · derivative · entry 1

Evans Carl Anthony · CIK 0001792582 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,594

Underlying: Common Stock · 17,500 shares

Expires 2034-04-08

F2 · price: The awards were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-24-000709 · ownership.xml · derivative · entry 1

Mahery Amy · CIK 0002008489 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,420

Underlying: Common Stock · 12,420 shares

Expires 2034-02-01

F2 · price: The options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The options set forth in this table vest in 36 equal monthly installments succeeding the issuance date, or February 1, 2024, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

SEC source: 0001683168-24-000706 · ownership.xml · derivative · entry 3

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,572

Underlying: Common Stock · 66,666 shares

Expires 2025-10-01

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000706 · ownership.xml · derivative · entry 2

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,906

Underlying: Common Stock · 66,666 shares

Expires 2029-02-01

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000706 · ownership.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,438

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000705 · ownership.xml · derivative · entry 3

Climaco John M · CIK 0001546797 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 393,533

Underlying: Common Stock · 166,666 shares

Expires 2025-10-01

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000705 · ownership.xml · derivative · entry 2

Climaco John M · CIK 0001546797 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 226,867

Underlying: Common Stock · 166,666 shares

Expires 2029-02-01

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000705 · ownership.xml · nonDerivative · entry 1

Climaco John M · CIK 0001546797 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,676

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000708 · ownership.xml · derivative · entry 3

Gumulka Jerzy · CIK 0001793252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,094

Underlying: Common Stock · 33,333 shares

Expires 2025-10-01

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000708 · ownership.xml · derivative · entry 2

Gumulka Jerzy · CIK 0001793252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,761

Underlying: Common Stock · 33,333 shares

Expires 2029-02-01

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000708 · ownership.xml · nonDerivative · entry 1

Gumulka Jerzy · CIK 0001793252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,006

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000707 · ownership.xml · derivative · entry 3

Evans Carl Anthony · CIK 0001792582 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,094

Underlying: Common Stock · 33,333 shares

Expires 2025-10-01

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000707 · ownership.xml · derivative · entry 2

Evans Carl Anthony · CIK 0001792582 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,761

Underlying: Common Stock · 33,333 shares

Expires 2029-02-01

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-24-000707 · ownership.xml · nonDerivative · entry 1

Evans Carl Anthony · CIK 0001792582 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,458

F1 · price: The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

SEC source: 0001683168-23-006678 · ownership.xml · derivative · entry 1

Charles Faith L. · CIK 0001853985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,914

Underlying: Common Stock · 49,474 shares

Expires 2033-09-22

F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-23-006686 · ownership.xml · derivative · entry 1

Keyes Jeffry R. · CIK 0001557736 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,914

Underlying: Common Stock · 68,961 shares

Expires 2033-09-22

F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-23-006684 · ownership.xml · derivative · entry 1

Gumulka Jerzy · CIK 0001793252 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,914

Underlying: Common Stock · 68,961 shares

Expires 2033-09-22

F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-23-006682 · ownership.xml · derivative · entry 1

Evans Carl Anthony · CIK 0001792582 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,914

Underlying: Common Stock · 68,961 shares

Expires 2033-09-22

F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-23-006680 · ownership.xml · derivative · entry 1

Cockroft Bettina M. · CIK 0001900452 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,914

Underlying: Common Stock · 18,650 shares

Expires 2033-09-22

F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-23-006676 · ownership.xml · derivative · entry 1

Andraczke Andrzej · CIK 0001792732 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,914

Underlying: Common Stock · 68,961 shares

Expires 2033-09-22

F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.

SEC source: 0001683168-23-007107 · ownership.xml · derivative · entry 1

Charles Faith L. · CIK 0001853985 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,815

Underlying: Common Stock · 26,315 shares

Expires 2033-09-22

F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company.

F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.